Back to School: How biopharma can reboot drug development. Access exclusive analysis here

XOMA Corp. regulatory update

The Berkeley, Calif., company received U.S. Patent No. 5,284,756

Read the full 95 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE